An international clinical trial has begun enrolling patients in the Democratic Republic of the Congo (DRC) in a step towards identifying the first effective treatment for Bundibugyo.

The Bundibugyo strain has no approved vaccine or targeted treatment, leaving supportive care as the primary option.

L'Organizzazione mondiale della sanità avvia il reclutamento dei pazienti per il trial PARTNERS nella Repubblica Democratica del Congo. In attesa di un vaccino, saranno valutati…